To compare the haemodynamic stabilizing effect of Etomidate in a group of hypertensive patients and another group of normotensive patients undergoing abdominal surgeries under general anesthesia.
Not Applicable
- Conditions
- Health Condition 1: I119- Hypertensive heart disease withoutheart failureHealth Condition 2: I158- Other secondary hypertension
- Registration Number
- CTRI/2021/05/033801
- Lead Sponsor
- SMS MEDICAL COLLEGE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA grade 1 and 2
Patients undergoing abdominal surgeries under general anesthesia
Normal patients and those with treated hypertension
Weight 40-80kg
Exclusion Criteria
Patients with untreated or uncontrolled hypertension
Patient not willing to give consent
Patient with baseline blood pressure less than 100/60mmHg and more than 160/110mmHg limits.
History of allergy or hypersensitivity to Etomidate.
Patients with unstable coronary arterial diseases.
Patients with diabetes mellitus,pheochromocytoma, adrenal cortex insufficiency.
Patients who are more than 30% over their ideal body weight.
Patients undergoing laparoscopic surgeries.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the Haemodynamic stabilizing effect of etomidate in hypertensive versus normotensive patients undergoing abdominal surgeries with general anesthesia by determining the difference of change in haemodynamic parameters in both the groupsTimepoint: First 10minutes after intubation
- Secondary Outcome Measures
Name Time Method To determine the difference in percentage of cases who may experience side effects in both group.Timepoint: 24hours